CW30190

General

Cell Line

hPSCreg Name
CIRMi879-A
Alternative name(s)
CW30190
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CIRMi886-A
(CW30197)
Donor diseases:
Dilated Cardiomyopathy
CIRMi887-A
(CW30198)
Donor diseases:
Dilated Cardiomyopathy
CIRMi889-A
(CW30200)
Donor diseases:
Dilated Cardiomyopathy
CIRMi890-A
(CW30202)
Donor diseases:
Dilated Cardiomyopathy
CIRMi891-A
(CW30203)
Donor diseases:
Dilated Cardiomyopathy
CIRMi892-A
(CW30204)
Donor diseases:
Dilated Cardiomyopathy
CIRMi895-A
(CW30208)
Donor diseases:
Dilated Cardiomyopathy
CIRMi898-A
(CW30211)
Donor diseases:
Dilated Cardiomyopathy
CIRMi899-A
(CW30212)
Donor diseases:
Dilated Cardiomyopathy
CIRMi901-A
(CW30214)
Donor diseases:
Dilated Cardiomyopathy
CIRMi902-A
(CW30215)
Donor diseases:
Dilated Cardiomyopathy
CIRMi905-A
(CW30220)
Donor diseases:
Dilated Cardiomyopathy
CIRMi906-A
(CW30221)
Donor diseases:
Dilated Cardiomyopathy
CIRMi907-A
(CW30222)
Donor diseases:
Dilated Cardiomyopathy
CIRMi911-A
(CW30226)
Donor diseases:
Dilated Cardiomyopathy
CIRMi913-A
(CW30228)
Donor diseases:
Dilated Cardiomyopathy
CIRMi914-A
(CW30229)
Donor diseases:
Dilated Cardiomyopathy
CIRMi916-A
(CW30231)
Donor diseases:
Dilated Cardiomyopathy
CIRMi917-A
(CW30232)
Donor diseases:
Dilated Cardiomyopathy
CIRMi918-A
(CW30233)
Donor diseases:
Dilated Cardiomyopathy
CIRMi921-A
(CW30236)
Donor diseases:
Dilated Cardiomyopathy
CIRMi922-A
(CW30237)
Donor diseases:
Dilated Cardiomyopathy
CIRMi923-A
(CW30238)
Donor diseases:
Dilated Cardiomyopathy
CIRMi925-A
(CW30241)
Donor diseases:
Dilated Cardiomyopathy
CIRMi927-A
(CW30243)
Donor diseases:
Dilated Cardiomyopathy
CIRMi930-A
(CW30246)
Donor diseases:
Dilated Cardiomyopathy
CIRMi933-A
(CW30249)
Donor diseases:
Dilated Cardiomyopathy
CIRMi934-A
(CW30251)
Donor diseases:
Dilated Cardiomyopathy
CIRMi935-A
(CW30253)
Donor diseases:
Dilated Cardiomyopathy
CIRMi938-A
(CW30257)
Donor diseases:
Dilated Cardiomyopathy
CIRMi939-A
(CW30258)
Donor diseases:
Dilated Cardiomyopathy
CIRMi942-A
(CW30261)
Donor diseases:
Dilated Cardiomyopathy
CIRMi943-A
(CW30262)
Donor diseases:
Dilated Cardiomyopathy
CIRMi945-A
(CW30264)
Donor diseases:
Dilated Cardiomyopathy
CIRMi950-A
(CW30269)
Donor diseases:
Dilated Cardiomyopathy
CIRMi951-A
(CW30270)
Donor diseases:
Dilated Cardiomyopathy
CIRMi952-A
(CW30272)
Donor diseases:
Dilated Cardiomyopathy
CIRMi953-A
(CW30273)
Donor diseases:
Dilated Cardiomyopathy
CIRMi954-A
(CW30274)
Donor diseases:
Dilated Cardiomyopathy
CIRMi956-A
(CW30276)
Donor diseases:
Dilated Cardiomyopathy
CIRMi957-A
(CW30279)
Donor diseases:
Dilated Cardiomyopathy
CIRMi958-A
(CW30280)
Donor diseases:
Dilated Cardiomyopathy
CIRMi959-A
(CW30282)
Donor diseases:
Dilated Cardiomyopathy
CIRMi960-A
(CW30283)
Donor diseases:
Dilated Cardiomyopathy
CIRMi961-A
(CW30284)
Donor diseases:
Dilated Cardiomyopathy
CIRMi962-A
(CW30285)
Donor diseases:
Dilated Cardiomyopathy
CIRMi963-A
(CW30286)
Donor diseases:
Dilated Cardiomyopathy
CIRMi964-A
(CW30287)
Donor diseases:
Dilated Cardiomyopathy
CIRMi973-A
(CW30298)
Donor diseases:
Dilated Cardiomyopathy
CIRMi975-A
(CW30300)
Donor diseases:
Dilated Cardiomyopathy
Last update 26th September 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator California Institute for Regenerative Medicine (CIRM)
Owner California Institute for Regenerative Medicine (CIRM)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA114427181
CLO CLO_0106024

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 60-64

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Dilated Cardiomyopathy
DILATED CARDIOMYOPATHY
Synonyms
  • Congestive Cardiomyopathy
  • Dilated Cardiomyopathy

External Databases (Donor)

BioSamples SAMEA114427182

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: info@cirm.ca.gov
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink info@cirm.ca.gov
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Stanford University
Approval number eprotocol 27543
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Stanford University
Approval number eprotocol 27543
Is there an MTA available for the cell line? Yes

hIPSC Derivation

General

Source cell type
blood cell
A cell found predominately in the blood.
Age of donor (at collection) 60-64

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
Lin28
Yes
Undifferentiated cells were analyzed by proprietary assays approved by California Institute of Regenerative Medicine (CIRM) as described in the attached publication. Pluripotency of established iPSC cultures were tested by qPCR on bulk samples using 48 genes including standard pluripotency genes (listed above). Samples were assigned a passing score after analysis with a non-supervised classifier based on an appropriate sample set. (Novak, T. 2015. Drug Discovery World pp. 47-53.)
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal

Other Genotyping (Cell Line)